Immunovant
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immunovant and other ETFs, options, and stocks.About IMVT
Immunovant, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases. It is developing a novel, fully human monoclonal antibody IMVT-1401 that selectively binds to and inhibits the neonatal fragment crystallizable receptor.
IMVT Key Statistics
Stock Snapshot
The current Immunovant(IMVT) stock price is $26.41, with a market capitalization of 5.37B. The stock trades at a price-to-earnings (P/E) ratio of -9.94.
On 2026-03-09, Immunovant(IMVT) stock moved within a range of $24.41 to $26.84. With shares now at $26.41, the stock is trading +8.2% above its intraday low and -1.6% below the session's peak.
Trading volume for Immunovant(IMVT) stock has reached 1.21M, versus its average volume of 1.1M.
Over the past 52 weeks, Immunovant(IMVT) stock has traded between a high of $29.25 and a low of $12.72.
Over the past 52 weeks, Immunovant(IMVT) stock has traded between a high of $29.25 and a low of $12.72.
Analyst ratings
76%
of 17 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.